Avanos Medical (AVNS) Cash from Investing Activities (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Cash from Investing Activities data on file, last reported at -$7.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 15.38% year-over-year to -$7.7 million; the trailing twelve-month figure through Mar 2026 stood at -$59.2 million (down 71.1% YoY), and the FY2025 full-year result was -$60.6 million, down 120.36% from the prior year.
• Cash from Investing Activities declined to -$7.7 million in Q1 2026, from -$6.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $81.0 million in Q4 2023 to a low of -$121.7 million in Q1 2022.
• A 5-year average of -$12.3 million and a median of -$6.8 million in 2025 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities tumbled 2035.09% in 2022 and surged 1753.06% in 2023, its largest moves.
• Tracing AVNS's Cash from Investing Activities over 5 years: stood at -$4.9 million in 2022, then surged by 1753.06% to $81.0 million in 2023, then plunged by 109.38% to -$7.6 million in 2024, then increased by 10.53% to -$6.8 million in 2025, then decreased by 13.24% to -$7.7 million in 2026.
• Business Quant data shows AVNS's Cash from Investing Activities at -$7.7 million in Q1 2026, -$6.8 million in Q4 2025, and -$31.5 million in Q3 2025.